Enhancement of cisplatin sensitivity in high mobility group 2 cDNA-transfected human lung cancer cells

Japanese Journal of Cancer Research

Volumn 90, Issue 1, 1999, Pages 108-115

  Arioka, Hitoshi ^a,b   Nishio, Kazuto ^a   Ishida, Tomoyuki ^a   Fukumoto, Hisao ^a   Fukuoka, Kazuya ^a   Nomoto, Taisuke ^a   Kurokawa, Hirokazu ^a   Yokote, Hideyuki ^a   Abe, Shosaku ^b   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cisplatin; HMG2; Interstrand cross link DNA repair

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; GLUTATHIONE; HIGH MOBILITY GROUP PROTEIN; MESSENGER RNA; PLATINUM;

ARTICLE; CANCER CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DNA CROSS LINKING; DNA DAMAGE; DNA PROTEIN COMPLEX; DNA REPAIR; DRUG SENSITIVITY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; SALMON; SPERM;

EID: 0033007981     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00673.x     Document Type: Article

References (37)

1. Bustin, M., Lehn, D. A. and Landsman, D. Structural features of the HMG chromosomal proteins and their genes. Biochim. Biophys. Acta, 1049, 231-243 (1990).
2. McA'Nulty, M. M. and Lippard, S. J. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutat. Res., 362, 75-86 (1996).
3. McA'Nulty, M. M., Whitehead, J. P. and Lippard, S. J. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo. Biochemistry, 35, 6089-6099 (1996).
4. Baxevanis, A. D. and Landsman, D. The HMG-1 box protein family: classification and functional relationships. Nucleic Acids Res., 23, 1604-1613 (1995).
5. Alexandrova, E. A., Marekov, L. N. and Beltchev, B. G. Involvement of protein HMG1 in DNA replication. FEBS Lett., 178, 153-155 (1984).
6. Bonne-Andrea, C., Harper, F., Puvion, E., Delpech, M. and De Recondo, A. M. Nuclear accumulation of HMG1 protein is correlated to DNA synthesis. Biol. Cell., 58, 185-194 (1986).
7. Tremethick, D. J. and Molloy, P. L. High mobility group proteins 1 and 2 stimulate transcription in vitro by RNA polymerases II and III. J. Biol. Chem., 261, 6986-6992 (1986).
8. Watt, F. and Molloy, P. L. High mobility group proteins 1 and 2 stimulate binding of a specific transcription factor to the adenovirus major late promoter. Nucleic Acids Res., 16, 1471-1486 (1988).
9. Yamazaki, F., Nagatsuka, Y., Shirakawa, H. and Yoshida, M. Repression of cell cycle progression by antisense HMG2 RNA. Biochem. Biophys. Res. Commun., 210, 1045-1051 (1995).
10. Pil, P. M. and Lippard, S. J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science, 256, 234-237 (1992).
11. Billings, P. C., Davis, R. J., Engelsberg, B. N., Skov, K. A. and Hughes, E. N. Characterization of high mobility group protein binding to cisplatin-damaged DNA. Biochem. Biophys. Res. Commun., 188, 1286-1294 (1992).
12. Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J. and Sancar, A. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proc. Natl. Acad. Sci. USA, 91, 10394-10398 (1994).
13. Nishio, M., Arioka, H., Nishio, K., Kubota, N., Heike, Y., Ohata, M. and Saijo, N. Overexpression of cisplatin-inducible proteins that are recognized by anti-HMG antibody in cisplatin-resistant human lung cancer cell lines. Cell. Pharmacol., 1, 251-255 (1994).
14. Majumdar, A., Brown, D., Kerby, S., Rudzinski, I., Polte, T., Randhawa, Z. and Seidman, M. M. Sequence of human HMG2 cDNA. Nucleic Acids Res., 19, 23 (1991).
15. Shirakawa, H. and Yoshida, M. Structure of a gene coding for human HMG2 protein. J. Biol. Chem., 267, 6641-6645 (1992).
16. Nakagawa., K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M. and Tew, K. D. Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 265, 4296-4301 (1990).
17. Fujiwara, Y., Kasahara, K., Sugimoto, Y., Nishio, K., Ohmori, T. and Saijo, N. Detection of proteins that recognize platinum-modified DNA using gel mobility shift assay. Jpn. J. Cancer Res., 81, 1210-1213 (1990).
18. Lee, K. A., Bindereif, A. and Green, M. R. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal. Tech., 5, 22-31 (1988).
19. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983).
20. Kurokawa, H., Ishida, T., Nishio, K., Arioka, H., Sata, M., Fukumoto, H., Miura, M. and Saijo, N. γ-Glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance. Biochem. Biophys. Res. Commun., 216, 258-264 (1995).
21. Kohn, K. W., Ewig, R. A. G., Erickson, L. C. and Zwelling, L. A. Measurement of strand breaks and cross-links by alkaline elution. In "DNA Repair: A Laboratory Manual of Research Procedures," ed. E. C. Friedberg and P. C. Hanawalt, Vol. 1B, pp. 379-401 (1981). Marcel Dekker, Inc., New York.
22. Bungo, M., Fujiwara, Y., Kasahara, K., Nakagawa, K., Ohe, Y., Sasaki, Y., Irino, S. and Saijo, N. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum (II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair. Cancer Res., 50, 2549-2553 (1990).
23. Kasahara, K., Fujiwara, Y., Nishio, K., Ohmori, T., Sugimoto, Y., Komiya, K., Matsuda, T. and Saijo, N. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res., 51, 3237-3242 (1991).
24. Morikage, T., Ohmori, T., Nishio, K., Fujiwara, Y., Takeda, Y. and Saijo, N. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res., 53, 3302-3307 (1991).
25. Andrews, P. A. and Howell, S. B. Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35-43 (1990).
26. Chu, G. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. J. Biol. Chem., 269, 787-790 (1994).
27. Chu, G. and Chang, E. Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNA. Science, 242, 564-567 (1988).
28. Clugston, C. K., McLaughlin, K., Kenny, M. K. and Brown, R. Binding of human single-stranded DNA binding protein to DNA damaged by the anticancer drug cis-diamminedichloroplatinum (II). Cancer Res., 52, 6375-6379 (1992).
29. Hughes, E. N., Engelsberg, B. N. and Billings, P. C. Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2. J. Biol. Chem., 267, 13520-13527 (1992).
30. Chow, C. S., Barnes, C. M. and Lippard, S. J. A single HMG domain in high-mobility group 1 protein binds to DNAs as small as 20 base pairs containing the major cisplatin adduct. Biochemistry, 34, 2956-2964 (1995).
31. Bruhn, S. L., Pil, P. M., Essigmann, J. M., Housman, D. E. and Lippard, S. J. Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin. Proc. Natl. Acad. Sci. USA, 89, 2307-2311 (1992).
32. Brown, S. J., Kellett, P. J. and Lippard, S. J. Ixr1, a yeast protein that hinds to platinated DNA and confers sensitivity to cisplatin. Science, 261, 603-605 (1993).
33. Masuda, H., Ozols, R. F., Lai, G. M., Fojo, A., Rothenberg, M. and Hamilton, T. C. Increased DNA repair us a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res., 48, 5713-5716 (1988).
34. Sherman, S. K. and Lippard, S. J. Structural aspects of platinum anticancer drug interactions with DNA. Chem. Rev., 87, 1153-1181 (1987).
35. Plooy, A. C. M., van Dijk, M., Berends, F. and Lohman, P. H. M. Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum (II). Cancer Res., 45, 4178-4184 (1985).
36. Levy, E., Baroche, C., Barret, J. M., Alapelite, C., Salles, B., Averbeck, D. and Moustacchi, E. Activated ras oncogene and specifically acquired resistance to cisplatin in human mammary epithelial cells: induction of DNA cross-links and their repair. Carcinogenesis, 15, 845-850 (1994).
37. Zhen, W., Link, C., Jr., O-Connor, P. M., Reed, H., Parker, R., Howell, S. B. and Bohr, V. A. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol. Cell. Bio., 12, 3689-3698 (1992).